These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8411030)

  • 21. Psychosocial impact of the lack of information given at referral about familial risk for cancer.
    Metcalfe A; Werrett J; Burgess L; Clifford C
    Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Learning about ovarian cancer at the time of diagnosis: video versus usual care.
    Geller MA; Downs LS; Judson PL; Ghebre R; Argenta PA; Carson LF; Jonson AL; Godfrey K; Vogel RI; Petzel SV
    Gynecol Oncol; 2010 Nov; 119(2):370-5. PubMed ID: 20673972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
    Bluman LG; Rimer BK; Berry DA; Borstelmann N; Iglehart JD; Regan K; Schildkraut J; Winer EP
    J Clin Oncol; 1999 Mar; 17(3):1040-6. PubMed ID: 10071299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychological adjustment to familial-genetic risk assessment for ovarian cancer: predictors of nonadherence to surveillance recommendations.
    Ritvo P; Irvine J; Robinson G; Brown L; Murphy KJ; Matthew A; Rosen B
    Gynecol Oncol; 2002 Jan; 84(1):72-80. PubMed ID: 11748980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Awareness of Risk Factors, Symptoms and Time to Seek Medical Help of Ovarian Cancer amongst Omani Women Attending Teaching Hospital in Muscat Governorate, Oman.
    Al-Azri M; Al-Saidi M; AL-Mutair E; Panchatcharam SM
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1833-1843. PubMed ID: 30049195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canadian women's perspectives on ovarian cancer.
    Fitch MI; Gray RE; DePetrillo D; Franssen E; Howell D
    Cancer Prev Control; 1999 Feb; 3(1):52-60. PubMed ID: 10474753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraceptive use in women at increased risk of breast/ovarian cancer: knowledge and attitudes.
    Bui KT; Wakefield CE; Kasparian NA; Tyler J; Abbott J; Tucker K
    Psychooncology; 2013 Jan; 22(1):228-32. PubMed ID: 21905159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Withdrawal from familial ovarian cancer screening for surgery: findings from a psychological evaluation study (PsyFOCS).
    Lifford KJ; Fraser L; Rosenthal AN; Rogers MT; Lancastle D; Phelps C; Watson EK; Clements A; Iredale R; Jacobs I; Menon U; Brain KE
    Gynecol Oncol; 2012 Jan; 124(1):158-63. PubMed ID: 21999920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influences on anticipated time to ovarian cancer symptom presentation in women at increased risk compared to population risk of ovarian cancer.
    Smits S; Boivin J; Menon U; Brain K
    BMC Cancer; 2017 Dec; 17(1):814. PubMed ID: 29202783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitudes about genetic testing for breast-ovarian cancer susceptibility.
    Lerman C; Daly M; Masny A; Balshem A
    J Clin Oncol; 1994 Apr; 12(4):843-50. PubMed ID: 8151327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Familial ovarian cancer syndrome].
    Bösze P
    Orv Hetil; 1994 Feb; 135(9):459-64. PubMed ID: 8139849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Women's awareness of ovarian cancer risks and symptoms.
    Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
    Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study.
    Bergfeldt K; Rydh B; Granath F; Grönberg H; Thalib L; Adami HO; Hall P
    Lancet; 2002 Sep; 360(9337):891-4. PubMed ID: 12354469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.
    Jeffers L; Morrison PJ; McCaughan E; Fitzsimons D
    Eur J Oncol Nurs; 2014 Aug; 18(4):411-8. PubMed ID: 24731853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using the Health Belief Model to explore why women decide for or against the removal of their ovaries to reduce their risk of developing cancer.
    Herrmann A; Hall A; Proietto A
    BMC Womens Health; 2018 Nov; 18(1):184. PubMed ID: 30428865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study on the psychosocial aspects of risk-reducing salpingo-oophorectomy (RRSO) in BRCA1/2 mutation carriers in Japan: a preliminary report.
    Shigehiro M; Kita M; Takeuchi S; Ashihara Y; Arai M; Okamura H
    Jpn J Clin Oncol; 2016 Mar; 46(3):254-9. PubMed ID: 26685323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer.
    Parker PA; Kudelka A; Basen-Engquist K; Kavanagh J; de Moor J; Cohen L
    Gynecol Oncol; 2006 Mar; 100(3):495-500. PubMed ID: 16242759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.